Recurring concern

Failure to secure and control medication

Pin Get email alerts Request correction

First reported 14 Mar 2014•Latest report 17 Dec 2025

Definition

What this concern includes

Includes failures of the medication-security and control process, including medication brought into care, patients’ own medication, prescribed medication and medication held in healthcare or custodial settings, where the concern is preventing unauthorised access, trading, theft, overdose or misuse.

Not included

  • Excludes medication prescribing, review or quantity decisions unless the report directly concerns securing or controlling the medication.
  • Excludes generic ward, premises or physical-access security concerns that are not specifically about medication.
  • Excludes medication information, counselling or handover failures unless they directly result in inadequate medication security or control.
  • Excludes unrelated clinical governance, staffing or documentation deficiencies that are not tied to medication security or control.
Reports
30

Distinct published reports

Individual concerns
34

A report can raise multiple concerns

Date range
2014–2025

First to latest report issue date

Stated actions
62

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

HM Prison and Probation Service6
Care UK3
Department of Health and Social Care3
Ministry of Justice3
Care Quality Commission2
Guys Marsh Prison2
NHS England2
Office of the Chief Coroner2
Advisory Council on the Misuse of Drugs1
APEX Prime Care1
Barts Health NHS Trust1
Birmingham and Solihull Mental Health NHS Foundation Trust1
Cardiff & Vale University LHB1
Central and North West London NHS Foundation Trust1
City and County Healthcare Group Limited1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Manchester South

    AI-generated summary

    Aaron John Peter McCaffrey · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Aaron John Peter McCaffrey had a history of addiction to loperamide and regularly took large quantities. After taking around 250 tablets on 13 January 2017, he collapsed, was admitted to hospital, and died on 19 January 2017; the recorded conclusion was a drug-related death. The principal concern was that there was no apparent limit on the amount of loperamide that could be purchased from a single store, facilitating large-quantity purchases and creating a risk of overdose and death.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of limits on the amount of loperamide medication purchasable from a single store

    Wider context from the report

    “The concern is that there is no apparent limit on the amount of loperamide medication that can be purchased from a single store. This makes the medication easier to purchase in large quantities. I am concerned that action should be taken to limit the amount of loperamide medication that can be purchased from a single store, due to the fact that it is apparently being used (on occasion) to fuel addiction and due to the risk of overdose and death. ”

    Source location

    Aaron John Peter McCaffrey · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    There is insufficient evidence that loperamide is frequently misused enough to warrant prescription-only classification.

    Verbatim wording from the response

    “Loperamide is available as a General Sale List (GSL) medicine and as a Pharmacy medicine under the supervision of a pharmacist. There are no restrictions on the numbers of packs which can be purchased. Pack sizes of up to 12 tablets/capsules are available GSL and larger packs are available in pharmacies. One of the criteria for Prescription Only classification is that a medicine is frequently and to a very wide extent used incorrectly, and as a result is likely to present a direct or indirect danger to human health. We do not consider that there is sufficient evidence that this criterion applies to loperamide. We have checked the report of the Advisory Council on Misuse of Drugs on Diversion and Illicit Supply of Medicines (DISM) from December 2016 and this has no mention of loperamide. The DISM report is available following this link:”

    Source location

    2017-0195_Redacted
    Page 1 · response
    Published 9 August 2017

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Responsible patients’ benefit from unrestricted retail access outweighs harms to the small number who deliberately misuse loperamide.

    Verbatim wording from the response

    “In particular, we have reflected on whether restricting the amount which can be purchased would have deterred a determined individual from obtaining such large quantities as in Mr McCaffrey’s case. On the evidence available to date, we consider that the benefit of access in retail outlets for those patients who use this medicine responsibly, outweighs the harms which may come to the very small number of individuals who deliberately misuse these medicines.”

    Source location

    2017-0195_Redacted
    Page 2 · response
    Published 9 August 2017

    Open published response
  2. Birmingham and Solihull

    AI-generated summary

    Patricia Ann Cleghorn · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Patricia Ann Cleghorn, who had suicidal ideation and was awaiting an inpatient mental health bed, was found collapsed at home after receiving diazepam and was declared dead by paramedics on 14 December 2015. The concerns were the lack of an available inpatient bed, allowing her to self-medicate with potentially dangerous drugs despite repeated statements that she intended to overdose, and the absence of a formal risk assessment.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to control access to available medication for a person at risk of overdose

    Wider context from the report

    “(2) The deceased had repeatedly stated that she would end her life by taking an overdose. Despite this she was left at home self-medicating drugs including amitriptyline, MST and oromorph. No formal risk assessment was undertaken and staff failed to appreciate what drugs she had available to her. ”

    Source location

    Patricia Ann Cleghorn · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Take action to manage the medicines-policy breach.

    Verbatim wording from the response

    “Proposed Action Plan – All of the actions are in place with the exception of item 4 which will be delivered by the end of November 2016”

    Source location

    2016-0270-Response-by-Birmingham-and-Solihull-NHS-Trust
    Page 4 · response
    Published 25 July 2016

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Issue a formal practice alert reinforcing suicide-risk, medicines-management and safe-medication-administration requirements, with staff acknowledgement.

    Verbatim wording from the response

    “2. The Senior Nurse for Professional Standards issued a formal practice alert on 12th September 2016 to registered and unregistered clinicians in our crisis and community teams to reinforce the requirements for:”

    Source location

    2016-0270-Response-by-Birmingham-and-Solihull-NHS-Trust
    Page 4 · response
    Published 25 July 2016

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Review the Medicines Code and supporting staff guidance to address medication-administration and risk-assessment issues, and report through internal governance.

    Verbatim wording from the response

    “Proposed Action Plan – All of the actions are in place with the exception of item 4 which will be delivered by the end of November 2016”

    Source location

    2016-0270-Response-by-Birmingham-and-Solihull-NHS-Trust
    Page 4 · response
    Published 25 July 2016

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    The Trust is responsible for addressing concerns about medication access, risk assessment and staff recognition of available drugs.

    Verbatim wording from the response

    “The second issue is one for the Trust to answer:”

    Source location

    2016-0270-Response-by-Department-of-Health
    Page 1 · response
    Published 25 July 2016

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Medication checks and removal of excessive medicines are limited by service users’ capacity and willingness to disclose information and permit searches.

    Verbatim wording from the response

    “Where risks are identified then medicines supply should be tightly controlled and overall medicines possession checked regularly as far as possible. If indicated, following appropriate risk assessment we will work with service users and carers to remove excessive medication in the interests of safety. It has to be recognised that we have to work within reasonable limits which are determined by the services user’s capacity and preparedness to fully disclose information and allow checks/searches. If our staff are in any way unsure that it is safe to supply medication, the team will need to consider whether to withhold supply and explain why.”

    Source location

    2016-0270-Response-by-Birmingham-and-Solihull-NHS-Trust
    Page 4 · response
    Published 25 July 2016

    Open published response
  3. Manchester West

    AI-generated summary

    Maureen Chatterley · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Maureen Chatterley died at Royal Bolton Hospital on 24 December 2014 after a fall causing a right hip fracture, subsequent dislocations and multiple surgical procedures. The report raised concerns that a possible excess dose of lorazepam was not investigated and that medication stock in patient drawers and ward cupboards was not recorded or controlled, although the Inquest accepted that any excess dose did not contribute to her death.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of continuous stock records and verification for non-controlled ward medications

    Wider context from the report

    “1. During the Inquest evidence was heard that i. There was no investigation by the hospital in relation to the concerns expressed by the family in relation to the administration of an excess dose of Lorazepam. ii. There was no record of the stock of medication in relation to non-controlled drugs in the medication drawer allocated to a patient nor in and the medication cupboard on the ward. Accordingly medication could be removed from the medication cupboard on the ward and used either for an elicit purpose or excess dosage without any knowledge or record with reference to stock control. Evidence was given at the Inquest that the pharmacist checked medications on the ward on a daily basis but there was no check or record of the number of medications or the number of tablets in the allocated medication drawers or the cupboard on ward, particularly between the daily inspections by the pharmacist. ”

    Source location

    Maureen Chatterley · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Audit all clinical areas quarterly against safe and secure medicines-handling standards and discuss results with ward managers.

    Verbatim wording from the response

    “All clinical areas are audited quarterly, by pharmacy staff, against these standards and the results are discussed with the ward managers. In addition to this the Medicines Safety Group has recently introduced additional measures to audit the security of medicines by introducing the NHS Protect’s Medicines Security Ward/Department checklist. These are completed by ward staff and collated for each division and the results and action plans discussed at the Medicines Safety Group. Copies of both audit forms have been included for information.”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 1 · response
    Published 8 October 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Use the NHS Protect Medicines Security Ward/Department checklist to audit medicines security, collate divisional results and agree action plans.

    Verbatim wording from the response

    “All clinical areas are audited quarterly, by pharmacy staff, against these standards and the results are discussed with the ward managers. In addition to this the Medicines Safety Group has recently introduced additional measures to audit the security of medicines by introducing the NHS Protect’s Medicines Security Ward/Department checklist. These are completed by ward staff and collated for each division and the results and action plans discussed at the Medicines Safety Group. Copies of both audit forms have been included for information.”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 1 · response
    Published 8 October 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Operate one-stop dispensing to use patients’ own medicines, reduce stock-medicine use and record dispensing and stock-review information electronically.

    Verbatim wording from the response

    “To facilitate the flow of patients through the organisation, Bolton NHS Foundation Trust has in place a one stop dispensing process. This not only encourages the use of patients own drugs during admission but also encourages the dispensing of medicines to patients for individual use, therefore reducing the use of stock medicines. The process in pharmacy provides a permanent record in the patient’s shared electronic record of the date of dispensing, the quantity supplied and a date to review the stock levels and need for re-supply before the supply is exhausted.”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 2 · response
    Published 8 October 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Introduce a new Wardex recording pharmacists’ clinical reviews and medicine supply.

    Verbatim wording from the response

    “Action | Target Date | To be actioned by Introduce new Wardex, which includes a section for pharmacists to record reviews of the wardex. This includes the clinical review and supply of medicines | Dec 2015 | Medicines Safety Group Develop and implement a local endorsement policy by pharmacy staff of the Wardex, to include supply and quantity details. | Feb 2016 | Medicines Safety Group Safe and Secure Handling of Medicines Audits (Duthie) to be presented to Medicines Safety Group for discussion and agreement of action plans. | Dec 2015 | Medicines Safety Group”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 2 · response
    Published 8 October 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Develop and implement a pharmacy policy endorsing Wardex entries, including medicine supply and quantity details.

    Verbatim wording from the response

    “Action | Target Date | To be actioned by Introduce new Wardex, which includes a section for pharmacists to record reviews of the wardex. This includes the clinical review and supply of medicines | Dec 2015 | Medicines Safety Group Develop and implement a local endorsement policy by pharmacy staff of the Wardex, to include supply and quantity details. | Feb 2016 | Medicines Safety Group Safe and Secure Handling of Medicines Audits (Duthie) to be presented to Medicines Safety Group for discussion and agreement of action plans. | Dec 2015 | Medicines Safety Group”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 2 · response
    Published 8 October 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Present Safe and Secure Handling of Medicines audit results to the Medicines Safety Group for discussion and agreement of action plans.

    Verbatim wording from the response

    “Action | Target Date | To be actioned by Introduce new Wardex, which includes a section for pharmacists to record reviews of the wardex. This includes the clinical review and supply of medicines | Dec 2015 | Medicines Safety Group Develop and implement a local endorsement policy by pharmacy staff of the Wardex, to include supply and quantity details. | Feb 2016 | Medicines Safety Group Safe and Secure Handling of Medicines Audits (Duthie) to be presented to Medicines Safety Group for discussion and agreement of action plans. | Dec 2015 | Medicines Safety Group”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 2 · response
    Published 8 October 2015

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Existing systems were considered sufficient to ensure ward medicines are stored securely and their stock can be verified.

    Verbatim wording from the response

    “I am confident that the Trust has the necessary systems in place to ensure that medication which is kept on wards is stored safely and securely and that the Trust is able to verify at any point in time the medication stored in both stock cupboards and patient’s medication drawers.”

    Source location

    2015-0404-Response-by-Bolton-NHS-Trust
    Page 2 · response
    Published 8 October 2015

    Open published response
  4. Worcestershire

    AI-generated summary

    Leonardus Adrianus VRIES · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Leonardus Adrianus Vries apparently obtained medical-grade drugs from his workplace and injected himself at his family home, where he died; the inquest concluded that his death was accidental, involving respiratory depression and combined toxicity of bupivacaine, morphine and diamorphine. The principal concern was inadequate documentation and auditing of medication, particularly non-controlled medication, at the Royal Orthopaedic Hospital, creating an opportunity for abuse or theft.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to audit and track the use of non-controlled medication

    Wider context from the report

    “Whilst the control of controlled medications appears to have been addressed by way of training and increased scrutiny and audit procedures ████████ confirms that there is still no audit of non-controlled medication. Specifically he said that when stocks of non-controlled medication are delivered to wards and departments there is no check as to who uses the medication or for what purpose. It appears to me therefore that there is a significant opportunity for the abuse or theft of non-controlled medication. ”

    Source location

    Leonardus Adrianus VRIES · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Conduct unannounced spot audits of theatre drug storage and documentation.

    Verbatim wording from the response

    “Since February 2015 a weekly audit of Controlled Drug documentation is carried out by theatres management. Since March 2015 the Chief Pharmacist has carried out unannounced spot audits (normally two per week) on drug storage (all drugs) and documentation in theatres. No concerns regarding diversion or theft of medicines have been identified through this audit cycle and all documentation is correctly completed.”

    Source location

    2015-0088-Response-by-Royal-Orthopaedic-Hospital
    Page 2 · response
    Published 9 March 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Review controls governing controlled and non-controlled medicines.

    Verbatim wording from the response

    “In summary, the controls around both Controlled Drugs and “non-controlled” drugs have been reviewed. Standard Operating Procedures for Controlled Drugs have been updated and audits conducted by the Chief Pharmacist have shown compliance with the standards required. Controls around “non-controlled” medicines have been reviewed and found to be compliant with or indeed exceed all national guidance. There remains a small risk that these medicines could be diverted as is the case in all hospitals. This is mitigated by the professional responsibilities of all staff regarding the use of medicines. To further mitigate”

    Source location

    2015-0088-Response-by-Royal-Orthopaedic-Hospital
    Page 2 · response
    Published 9 March 2015

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Continue monitoring drug-usage trends across all Trust areas to identify potential diversion risks.

    Verbatim wording from the response

    “this risk the Chief Pharmacist will continue to monitor trends in usage of drugs in all areas of the Trust.”

    Source location

    2015-0088-Response-by-Royal-Orthopaedic-Hospital
    Page 3 · response
    Published 9 March 2015

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Existing controls and professional responsibilities are considered sufficient to mitigate the small residual risk of medicine diversion.

    Verbatim wording from the response

    “In summary, the controls around both Controlled Drugs and “non-controlled” drugs have been reviewed. Standard Operating Procedures for Controlled Drugs have been updated and audits conducted by the Chief Pharmacist have shown compliance with the standards required. Controls around “non-controlled” medicines have been reviewed and found to be compliant with or indeed exceed all national guidance. There remains a small risk that these medicines could be diverted as is the case in all hospitals. This is mitigated by the professional responsibilities of all staff regarding the use of medicines. To further mitigate”

    Source location

    2015-0088-Response-by-Royal-Orthopaedic-Hospital
    Page 2 · response
    Published 9 March 2015

    Open published response
  5. Berkshire

    AI-generated summary

    Darren Linfoot · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Darren Linfoot was found unresponsive in his room at Broadmoor Hospital on 18 December 2011 and was declared deceased at Frimley Park Hospital. A post-mortem examination found lobar pneumonia as the cause of death, with dihydrocodeine toxicity contributing. Concerns included inadequate auditing of some potent medications, inconsistent four-hourly patient observations, and inconsistent understanding of the radio nurse’s duties.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to audit and monitor non-controlled potent medication

    Wider context from the report

    “(1) The evidence was that a variety of drugs and medications are dispensed from the hospital’s in-house pharmacy for use of individual patients on the individual wards. Only controlled drugs are audited and their whereabouts monitored. Among others, Opiate drugs are classed as non-controlled and therefore not audited. There is a real risk that potent medication could go unaccounted for and could end up in the possession of patients. ”

    Source location

    Darren Linfoot · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report
  6. Inner North London

    AI-generated summary

    Andrew James AITKEN · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Andrew Aitken was admitted to hospital on 10 June 2014 after taking a drug overdose, was treated and discharged on 16 June. Two months later he was found dead at home from amitriptyline toxicity, without having accessed mental health care in the meantime. Concerns included the handling of the remaining tablets, failure to seek records of a previous psychiatric admission, lack of direct referral to community mental health services despite him having no GP, and his discharge without clothes or shoes.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to safely secure medication brought into hospital

    Wider context from the report

    “1. When Mr Aitken was admitted to hospital on 10 June 2014, his girlfriend brought in the remainder of the tablets he had taken, hoping to assist those treating him. ████████ told me that a nurse took the tablets from her, of which there were still many remaining, and simply left them on the hospital bedside cabinet next to Mr Aitken. ”

    Source location

    Andrew James AITKEN · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  7. Exeter and Greater Devon

    AI-generated summary

    Andrew john Hooper · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Andrew John Hooper died after taking methadone prescribed to his girlfriend, with the stated cause of death being respiratory failure, hypoxic brain injury and methadone toxicity. The concerns were that the medication was not secured, was available in a quantity sufficient for a fatal dose, and that the person prescribed it appeared unaware of the risks to others and unable to keep it safe.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to secure medication

    Wider context from the report

    “(1) The medication was not secured, and was prescribed in sufficient quantity for a fatal dose to be taken by a user un-used to this medication. (bottle 420ml) (2) the person to whom was prescribed appeared to be unaware of the dangers of this medication, when taken by another in large quantities. (3) Consideration should be given to the appropriateness of prescribing to an individual who is not able or prepared to keep the medication safe and secure, or is not aware of the dangers of ingestion, (deliberate or otherwise), for others. If this means daily prescription, the balance of inconvenience versus the safety of others should be carefully weighed on an individual basis, and evidence recorded in this regard. ”

    Source location

    Andrew john Hooper · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report
  8. Surrey

    AI-generated summary

    Frances Claire ANDRADE · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Frances Claire Andrade died after taking an overdose of fluoxetine and insulin, following a period involving repeated overdoses and increasing distress around criminal proceedings. The report raised concerns about advice and support for vulnerable witnesses, explanations of trial directions, and securing medication prescribed to another family member after repeated overdoses.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to secure medication prescribed to one family member from access by another family member with a history of overdoses

    Wider context from the report

    “3. Where there is a history of overdoses being taken by family member A using medication that is prescribed to family member B, consideration should be given to what steps could reasonably be taken to secure that medication with a view to restricting access to it by family member A. ”

    Source location

    Frances Claire ANDRADE · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Require comprehensive collaborative risk-management care plans for identified medication-hoarding or overdose risks and share them with the involved care team.

    Verbatim wording from the response

    “Further to our own internal investigation we have since recommended that staff should ensure that when specific risks are identified in a person [e.g. a person is assessed to be hoarding medication and using other person’s prescribed medication to overdose], this must be followed by comprehensive risk management care plan/s in collaboration with the person/s and shared with the Team directly involved in the person’s care. We believe that a process managed through effective care planning arrangements with clear engagement with the person using our service and the carer, would be the most effective process that may go some way to mitigate this risk.”

    Source location

    2014-0347-Response-by-Surrey-and-Borders-Partnership-NHS
    Page 1 · response
    Published 28 July 2014

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Develop and use a local protocol for safe medication management, including safety plans with people and families where medication-overdose history is identified.

    Verbatim wording from the response

    “We monitor compliance with care planning through our Board Key Performance Indicators to ensure that the process of care planning remains embedded. Our Home Treatment Team has developed a local protocol to ensure safety of medication management and further to the investigation they are expected to establish a safety plan with the person and family for the safe storage of medication if a history of overdosing on family’s medication has been revealed.”

    Source location

    2014-0347-Response-by-Surrey-and-Borders-Partnership-NHS
    Page 2 · response
    Published 28 July 2014

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Limited influence over how the public stores medication makes it unrealistic to fully mitigate overdose risk through medication security.

    Verbatim wording from the response

    “Due to the limited influence we have on how members of the public store or manage their medication it will, unfortunately, be unrealistic for us to say we can fully mitigate against this risk going forward. We have however taken steps to ensure that our staff interactions with family carers and people using services recognise this risk and highlight it as an area to be considered by all parties involved.”

    Source location

    2014-0347-Response-by-Surrey-and-Borders-Partnership-NHS
    Page 1 · response
    Published 28 July 2014

    Open published response
  9. County Durham and Darlington

    AI-generated summary

    Edward John Devlin · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Edward John Devlin was found dead in his cell at HMP Durham on 17 July 2011, having died from the effects of dihydrocodeine. The report raised concerns that medication, including potentially dangerous drugs, may have been slid under locked cell doors without confirming receipt or administration, creating risks of diversion, inaccurate medication records, stockpiling and potentially lethal overdose. It also found that his physical condition on the night before his death warranted medical assessment, but no such assessment was carried out.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Unauthorised appropriation, trading and stockpiling of patient medication

    Wider context from the report

    “(1) It was stated by a nurse that he had, while dispensing medication to Mr Devlin and other patient on F wing, slid strips of medication including dihydrocodeine under locked cell doors instead of handing it to the patient. (2) He claimed this was his own common practice and was also common practice amongst nursing staff on F wing. This was in relation to potentially dangerous and/or tradable drugs like dihydrocodeine. (3) If this were the case, no one would know whether a patient is taking the medication intended for him. (4) Further, other healthcare professionals, assuming that medication was being taken by the patient, could base a future diagnosis upon this which would be potentially flawed. (5) Assessing any other patient would become fraught with uncertainty as healthcare professionals could never know for certain what medication had been taken by him. (6) The concomitant concern with 3, 4 and 5 above would be that the system whereby the dispensing of drugs is recorded by signatures of nurse and patient is either being ignored or subject to forgery. (7) Further, no one would know whether somebody else was appropriating that patient’s medication. (8) Depending on the type of medication, this may be traded within the establishment raising security concerns. (9) The drugs could be stockpiled with a view to creating a potentially lethal overdose. ”

    Source location

    Edward John Devlin · Prevention of Future Deaths report
    Page 4 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to ensure medication is handed directly to the intended patient

    Wider context from the report

    “(1) It was stated by a nurse that he had, while dispensing medication to Mr Devlin and other patient on F wing, slid strips of medication including dihydrocodeine under locked cell doors instead of handing it to the patient. (2) He claimed this was his own common practice and was also common practice amongst nursing staff on F wing. This was in relation to potentially dangerous and/or tradable drugs like dihydrocodeine. (3) If this were the case, no one would know whether a patient is taking the medication intended for him. (4) Further, other healthcare professionals, assuming that medication was being taken by the patient, could base a future diagnosis upon this which would be potentially flawed. (5) Assessing any other patient would become fraught with uncertainty as healthcare professionals could never know for certain what medication had been taken by him. (6) The concomitant concern with 3, 4 and 5 above would be that the system whereby the dispensing of drugs is recorded by signatures of nurse and patient is either being ignored or subject to forgery. (7) Further, no one would know whether somebody else was appropriating that patient’s medication. (8) Depending on the type of medication, this may be traded within the establishment raising security concerns. (9) The drugs could be stockpiled with a view to creating a potentially lethal overdose. ”

    Source location

    Edward John Devlin · Prevention of Future Deaths report
    Page 4 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Implement procedures to stop administering medication by sliding it under cell doors.

    Verbatim wording from the response

    “the cell door. This was limited to night time medication rounds as the requirement to open a cell door when in patrol state requires a senior prison officer to be present and the working arrangements at the time did not always allow this. At the time this was highlighted as a clinical risk and not appropriate. Procedures were therefore put in place to ensure this practice ceased.”

    Source location

    Response from Care UK
    Page 3 · response
    Published 22 July 2014

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Develop and obtain clinical-governance approval for a formal policy governing NIP medication when staff cannot open a cell door.

    Verbatim wording from the response

    “As part of investigation in the event of nursing staff not being able to administer NIP medication to a prisoner by opening the cell door, for example; the threat of violence from the individual or industrial action, I have identified that a formal policy should be developed and approved by Care UK clinical governance detailing the action required by nursing staff.”

    Source location

    Response from Care UK
    Page 4 · response
    Published 22 July 2014

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    There is no evidence that issuing in-possession medication under cell doors was common practice at HMP Durham.

    Verbatim wording from the response

    “There is no evidence to suggest that putting IP medication under the cell doors is common practice in HMP Durham.”

    Source location

    Response from Care UK
    Page 4 · response
    Published 22 July 2014

    Open published response
  10. Inner South London

    AI-generated summary

    Teresa Lonergan · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Teresa Lonergan, aged 73, was found dead at home on 4 September 2012 after taking an overdose of morphine that she had hoarded. The concerns included large quantities of prescribed morphine being available, repeat prescriptions and no reported monitoring of her consumption of controlled drugs.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to monitor consumption of prescribed controlled drugs

    Wider context from the report

    “(1) At the scene the following bottles of morphine were found: 1 100 ml bottle 10mg/5mls 10% remaining, dated 21/02/12 1 100 ml bottle 10mg/5ml 30% remaining, dated 09/03/12 1 100 ml bottle 10mg/5ml 33% remaining, dated 08/05/12 1 100 ml bottle 10mg/5ml 75% remaining ? date 1 100 ml bottle 10mg/5ml, full, dated 13/07/12 and 3 loose strips of 10mg Zomorph with 23 of 28 remaining It was calculated that if the liquid morphine alone was considered there was 340mg available. The pathologist advised that 100 to 200mg would probably be sufficient to cause a fatality. (2) She was a retired matron. She was visited twice daily by her care worker, who opened her bottles for her as she was not able to do so herself. She did not report any medical instructions from doctors about administration or monitoring. Her GP issued repeat prescriptions of: 10mg Zomorph MR3 capsules 1 dse (issue up to 120), last issued 03/05/12 Morphine sulphate 10mg/5ml qds prn (issue up to 200mls)last issued 11/07/12. This was in addition to regular benzodiazepines and other non controlled analgesia. It was reported that she was visited several times a year by the surgery and kept in contact on the phone. There was no report of any monitoring of her consumption of controlled drugs, but the evidence from the general practice was read. She appeared to continue to draw prescriptions but not consume them as prescribed, thus building up a hoard, and providing the means for a deliberate overdose to be taken. ”

    Source location

    Teresa Lonergan · Prevention of Future Deaths report
    Page 1 · concerns

    Open source report
Back to top

Data last updated 7 September 2026